Contrast enhanced ultrasound with Lumason for Kidney Cancer
This trial will help doctors better understand how to use imaging to grade renal cell carcinoma, which in turn will help them make treatment decisions.
- Kidney Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What risks have been associated with Contrast enhanced ultrasound using Lumason?
"A score of 3 reflects the fact that Contrast Enhanced Ultrasound with Lumason has been approved and is in Phase 4. Therefore, it can be assumed to have a high level of safety."
Is there an ongoing call for participants in this experiment?
"Absolutely, according to clinicaltrials.gov this medical trial is actively searching for volunteers and was first posted on July 16th 2019. The most recent update was recorded as of 12th July 2022, with the aim of finding 40 individuals at a single site."
Is this an original investigation?
"Utilizing Lumason with contrast enhanced ultrasound has been explored by researchers since 2017, when the first study to examine this intervention was sponsored by Bracco Diagnostics. Following a successful Phase < 1 drug approval in late 2017, 14 distinct medical studies have been launched across 10 urban centres located within 3 nations."
What is the recruitment size of this experiment?
"Correct. The information hosted on clinicaltrials.gov corroborates that this research trial, which was originally posted to the platform in July of 2019, is actively searching for participants. 40 patients are required from a single location."
Have there been precedents of Contrast enhanced ultrasound with Lumason in clinical trials?
"Currently, there are 14 active trials for Contrast enhanced ultrasound with Lumason, two of which currently reside in the third phase. Most take place at sites within Philadelphia, Pennsylvania; though overall there are 18 study locations across America."